The global Blood & Tissue DNA Kit market was valued at US$ 314 million in 2025 and is anticipated to reach US$ 488 million by 2032, at a CAGR of 6.3% from 2026 to 2032.

Blood & Tissue DNA Kit Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Blood & Tissue DNA Kit competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

In 2025, global Blood & Tissue DNA Kits approximately 3697 k units, with an average global market price of around US$ 85 per unit. Gross margin is about 48%. The cost is 44 usd. The Production is about 4200 k units. Blood & Tissue DNA Kit is a sample preparation reagent system used to isolate and purify high-quality genomic DNA from blood and tissue specimens through cell lysis, protein digestion, and DNA binding and elution processes. Upstream, it relies on lysis buffers, enzymes, spin columns or magnetic beads, and consumable plastics. Downstream, it serves as a fundamental input for PCR, qPCR, NGS library preparation, genotyping, and molecular diagnostics, and is widely used by clinical laboratories, research institutes, biotech companies, and diagnostic kit manufacturers as a core tool in molecular biology workflows.

The North American market for Blood & Tissue DNA Kit is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Blood & Tissue DNA Kit is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Blood & Tissue DNA Kit include QIAGEN, Thermo Fisher Scientific, Sigma-Aldrich (Merck), Roche, Axygen (Corning), Analytik Jena, Promega, Zymo Research, Illumina, Macherey-Nagel, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Blood & Tissue DNA Kit market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blood & Tissue DNA Kit. The Blood & Tissue DNA Kit market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Blood & Tissue DNA Kit market comprehensively. Regional market sizes by Type, by Application, by Technology, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Blood & Tissue DNA Kit manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Blood & Tissue DNA Kit Market Report

Report Metric	Details
Report Name	Blood & Tissue DNA Kit Market
Accounted market size in 2025	US$ 314 million
Forecasted market size in 2032	US$ 488 million
CAGR	6.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Whole Blood Plasma or Serum Buffy Coat
Segment by Technology	Spin Column-based DNA Kit Magnetic Bead-based DNA Kit Precipitation-based DNA Kit
by Application	R&D Organisations Biotechnology Companies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	QIAGEN, Thermo Fisher Scientific, Sigma-Aldrich (Merck), Roche, Axygen (Corning), Analytik Jena, Promega, Zymo Research, Illumina, Macherey-Nagel, Bio-Rad, Omega Bio-tek, Geneaid, Lucigen (Biosearch Technologies), Norgen, MGI Tech Co., Ltd., BioVision
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Technology, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Blood & Tissue DNA Kit manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Blood & Tissue DNA Kit sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Blood & Tissue DNA Kit Market growing?

Ans: The Blood & Tissue DNA Kit Market witnessing a CAGR of 6.3% during the forecast period 2026-2032.

What is the Blood & Tissue DNA Kit Market size in 2032?

Ans: The Blood & Tissue DNA Kit Market size in 2032 will be US$ 488 million.

Who are the main players in the Blood & Tissue DNA Kit Market report?

Ans: The main players in the Blood & Tissue DNA Kit Market are QIAGEN, Thermo Fisher Scientific, Sigma-Aldrich (Merck), Roche, Axygen (Corning), Analytik Jena, Promega, Zymo Research, Illumina, Macherey-Nagel, Bio-Rad, Omega Bio-tek, Geneaid, Lucigen (Biosearch Technologies), Norgen, MGI Tech Co., Ltd., BioVision

What are the Application segmentation covered in the Blood & Tissue DNA Kit Market report?

Ans: The Applications covered in the Blood & Tissue DNA Kit Market report are R&D Organisations, Biotechnology Companies

What are the Type segmentation covered in the Blood & Tissue DNA Kit Market report?

Ans: The Types covered in the Blood & Tissue DNA Kit Market report are Whole Blood, Plasma or Serum, Buffy Coat

1 Blood & Tissue DNA Kit Market Overview

1.1 Product Definition

1.2 Blood & Tissue DNA Kit by Type

1.2.1 Global Blood & Tissue DNA Kit Market Value by Type: 2025 vs 2032

1.2.2 Whole Blood

1.2.3 Plasma or Serum

1.2.4 Buffy Coat

1.3 Blood & Tissue DNA Kit by Technology

1.3.1 Global Blood & Tissue DNA Kit Market Value by Technology: 2025 vs 2032

1.3.2 Spin Column-based DNA Kit

1.3.3 Magnetic Bead-based DNA Kit

1.3.4 Precipitation-based DNA Kit

1.4 Blood & Tissue DNA Kit by Application

1.4.1 Global Blood & Tissue DNA Kit Market Value by Application: 2025 vs 2032

1.4.2 R&D Organisations

1.4.3 Biotechnology Companies

1.5 Global Blood & Tissue DNA Kit Market Size Estimates and Forecasts

1.5.1 Global Blood & Tissue DNA Kit Revenue 2021–2032

1.5.2 Global Blood & Tissue DNA Kit Sales 2021–2032

1.5.3 Global Blood & Tissue DNA Kit Market Average Price (2021–2032)

1.6 Assumptions and Limitations

2 Blood & Tissue DNA Kit Market Competition by Manufacturers

2.1 Global Blood & Tissue DNA Kit Sales Market Share by Manufacturers (2021–2026)

2.2 Global Blood & Tissue DNA Kit Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Blood & Tissue DNA Kit Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Blood & Tissue DNA Kit, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Blood & Tissue DNA Kit, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Blood & Tissue DNA Kit, Product Types and Applications

2.7 Global Key Manufacturers of Blood & Tissue DNA Kit, Date of Entry into the Industry

2.8 Global Blood & Tissue DNA Kit Market Competitive Situation and Trends

2.8.1 Global Blood & Tissue DNA Kit Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Blood & Tissue DNA Kit Players Market Share by Revenue

2.8.3 Global Blood & Tissue DNA Kit Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Blood & Tissue DNA Kit Market Scenario by Region

3.1 Global Blood & Tissue DNA Kit Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Blood & Tissue DNA Kit Sales by Region: 2021–2032

3.2.1 Global Blood & Tissue DNA Kit Sales by Region: 2021–2026

3.2.2 Global Blood & Tissue DNA Kit Sales by Region: 2027–2032

3.3 Global Blood & Tissue DNA Kit Revenue by Region: 2021–2032

3.3.1 Global Blood & Tissue DNA Kit Revenue by Region: 2021–2026

3.3.2 Global Blood & Tissue DNA Kit Revenue by Region: 2027–2032

3.4 North America Blood & Tissue DNA Kit Market Facts & Figures by Country

3.4.1 North America Blood & Tissue DNA Kit Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Blood & Tissue DNA Kit Sales by Country (2021–2032)

3.4.3 North America Blood & Tissue DNA Kit Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Blood & Tissue DNA Kit Market Facts & Figures by Country

3.5.1 Europe Blood & Tissue DNA Kit Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Blood & Tissue DNA Kit Sales by Country (2021–2032)

3.5.3 Europe Blood & Tissue DNA Kit Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Blood & Tissue DNA Kit Market Facts & Figures by Region

3.6.1 Asia Pacific Blood & Tissue DNA Kit Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Blood & Tissue DNA Kit Sales by Region (2021–2032)

3.6.3 Asia Pacific Blood & Tissue DNA Kit Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Blood & Tissue DNA Kit Market Facts & Figures by Country

3.7.1 Latin America Blood & Tissue DNA Kit Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Blood & Tissue DNA Kit Sales by Country (2021–2032)

3.7.3 Latin America Blood & Tissue DNA Kit Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Blood & Tissue DNA Kit Market Facts & Figures by Country

3.8.1 Middle East and Africa Blood & Tissue DNA Kit Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Blood & Tissue DNA Kit Sales by Country (2021–2032)

3.8.3 Middle East and Africa Blood & Tissue DNA Kit Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Blood & Tissue DNA Kit Sales by Type (2021–2032)

4.1.1 Global Blood & Tissue DNA Kit Sales by Type (2021–2026)

4.1.2 Global Blood & Tissue DNA Kit Sales by Type (2027–2032)

4.1.3 Global Blood & Tissue DNA Kit Sales Market Share by Type (2021–2032)

4.2 Global Blood & Tissue DNA Kit Revenue by Type (2021–2032)

4.2.1 Global Blood & Tissue DNA Kit Revenue by Type (2021–2026)

4.2.2 Global Blood & Tissue DNA Kit Revenue by Type (2027–2032)

4.2.3 Global Blood & Tissue DNA Kit Revenue Market Share by Type (2021–2032)

4.3 Global Blood & Tissue DNA Kit Price by Type (2021–2032)

5 Segment by Application

5.1 Global Blood & Tissue DNA Kit Sales by Application (2021–2032)

5.1.1 Global Blood & Tissue DNA Kit Sales by Application (2021–2026)

5.1.2 Global Blood & Tissue DNA Kit Sales by Application (2027–2032)

5.1.3 Global Blood & Tissue DNA Kit Sales Market Share by Application (2021–2032)

5.2 Global Blood & Tissue DNA Kit Revenue by Application (2021–2032)

5.2.1 Global Blood & Tissue DNA Kit Revenue by Application (2021–2026)

5.2.2 Global Blood & Tissue DNA Kit Revenue by Application (2027–2032)

5.2.3 Global Blood & Tissue DNA Kit Revenue Market Share by Application (2021–2032)

5.3 Global Blood & Tissue DNA Kit Price by Application (2021–2032)

6 Key Companies Profiled

6.1 QIAGEN

6.1.1 QIAGEN Company Information

6.1.2 QIAGEN Description and Business Overview

6.1.3 QIAGEN Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 QIAGEN Blood & Tissue DNA Kit Product Portfolio

6.1.5 QIAGEN Recent Developments/Updates

6.2 Thermo Fisher Scientific

6.2.1 Thermo Fisher Scientific Company Information

6.2.2 Thermo Fisher Scientific Description and Business Overview

6.2.3 Thermo Fisher Scientific Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Thermo Fisher Scientific Blood & Tissue DNA Kit Product Portfolio

6.2.5 Thermo Fisher Scientific Recent Developments/Updates

6.3 Sigma-Aldrich (Merck)

6.3.1 Sigma-Aldrich (Merck) Company Information

6.3.2 Sigma-Aldrich (Merck) Description and Business Overview

6.3.3 Sigma-Aldrich (Merck) Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Sigma-Aldrich (Merck) Blood & Tissue DNA Kit Product Portfolio

6.3.5 Sigma-Aldrich (Merck) Recent Developments/Updates

6.4 Roche

6.4.1 Roche Company Information

6.4.2 Roche Description and Business Overview

6.4.3 Roche Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Roche Blood & Tissue DNA Kit Product Portfolio

6.4.5 Roche Recent Developments/Updates

6.5 Axygen (Corning)

6.5.1 Axygen (Corning) Company Information

6.5.2 Axygen (Corning) Description and Business Overview

6.5.3 Axygen (Corning) Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Axygen (Corning) Blood & Tissue DNA Kit Product Portfolio

6.5.5 Axygen (Corning) Recent Developments/Updates

6.6 Analytik Jena

6.6.1 Analytik Jena Company Information

6.6.2 Analytik Jena Description and Business Overview

6.6.3 Analytik Jena Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Analytik Jena Blood & Tissue DNA Kit Product Portfolio

6.6.5 Analytik Jena Recent Developments/Updates

6.7 Promega

6.7.1 Promega Company Information

6.7.2 Promega Description and Business Overview

6.7.3 Promega Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Promega Blood & Tissue DNA Kit Product Portfolio

6.7.5 Promega Recent Developments/Updates

6.8 Zymo Research

6.8.1 Zymo Research Company Information

6.8.2 Zymo Research Description and Business Overview

6.8.3 Zymo Research Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Zymo Research Blood & Tissue DNA Kit Product Portfolio

6.8.5 Zymo Research Recent Developments/Updates

6.9 Illumina

6.9.1 Illumina Company Information

6.9.2 Illumina Description and Business Overview

6.9.3 Illumina Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Illumina Blood & Tissue DNA Kit Product Portfolio

6.9.5 Illumina Recent Developments/Updates

6.10 Macherey-Nagel

6.10.1 Macherey-Nagel Company Information

6.10.2 Macherey-Nagel Description and Business Overview

6.10.3 Macherey-Nagel Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Macherey-Nagel Blood & Tissue DNA Kit Product Portfolio

6.10.5 Macherey-Nagel Recent Developments/Updates

6.11 Bio-Rad

6.11.1 Bio-Rad Company Information

6.11.2 Bio-Rad Description and Business Overview

6.11.3 Bio-Rad Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Bio-Rad Blood & Tissue DNA Kit Product Portfolio

6.11.5 Bio-Rad Recent Developments/Updates

6.12 Omega Bio-tek

6.12.1 Omega Bio-tek Company Information

6.12.2 Omega Bio-tek Description and Business Overview

6.12.3 Omega Bio-tek Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Omega Bio-tek Blood & Tissue DNA Kit Product Portfolio

6.12.5 Omega Bio-tek Recent Developments/Updates

6.13 Geneaid

6.13.1 Geneaid Company Information

6.13.2 Geneaid Description and Business Overview

6.13.3 Geneaid Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Geneaid Blood & Tissue DNA Kit Product Portfolio

6.13.5 Geneaid Recent Developments/Updates

6.14 Lucigen (Biosearch Technologies)

6.14.1 Lucigen (Biosearch Technologies) Company Information

6.14.2 Lucigen (Biosearch Technologies) Description and Business Overview

6.14.3 Lucigen (Biosearch Technologies) Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Lucigen (Biosearch Technologies) Blood & Tissue DNA Kit Product Portfolio

6.14.5 Lucigen (Biosearch Technologies) Recent Developments/Updates

6.15 Norgen

6.15.1 Norgen Company Information

6.15.2 Norgen Description and Business Overview

6.15.3 Norgen Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Norgen Blood & Tissue DNA Kit Product Portfolio

6.15.5 Norgen Recent Developments/Updates

6.16 MGI Tech Co., Ltd.

6.16.1 MGI Tech Co., Ltd. Company Information

6.16.2 MGI Tech Co., Ltd. Description and Business Overview

6.16.3 MGI Tech Co., Ltd. Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.16.4 MGI Tech Co., Ltd. Blood & Tissue DNA Kit Product Portfolio

6.16.5 MGI Tech Co., Ltd. Recent Developments/Updates

6.17 BioVision

6.17.1 BioVision Company Information

6.17.2 BioVision Description and Business Overview

6.17.3 BioVision Blood & Tissue DNA Kit Sales, Revenue, and Gross Margin (2021–2026)

6.17.4 BioVision Blood & Tissue DNA Kit Product Portfolio

6.17.5 BioVision Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Blood & Tissue DNA Kit Industry Chain Analysis

7.2 Blood & Tissue DNA Kit Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Blood & Tissue DNA Kit Production Mode & Process Analysis

7.4 Blood & Tissue DNA Kit Sales and Marketing

7.4.1 Blood & Tissue DNA Kit Sales Channels

7.4.2 Blood & Tissue DNA Kit Distributors

7.5 Blood & Tissue DNA Kit Customer Analysis

8 Blood & Tissue DNA Kit Market Dynamics

8.1 Blood & Tissue DNA Kit Industry Trends

8.2 Blood & Tissue DNA Kit Market Drivers

8.3 Blood & Tissue DNA Kit Market Challenges

8.4 Blood & Tissue DNA Kit Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Qiagen NV

Thermo Fisher Scientific

Lucigen (Biosearch Technologies)

Norgen

MGI Tech Co., Ltd

BioVision

List of Tables

Table 1. Global Blood & Tissue DNA Kit Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Blood & Tissue DNA Kit Market Value by Technology (US$ Million), 2025 vs 2032

Table 3. Global Blood & Tissue DNA Kit Market Value by Application (US$ Million), 2025 vs 2032

Table 4. Global Blood & Tissue DNA Kit Market Competitive Situation by Manufacturers in 2025

Table 5. Global Blood & Tissue DNA Kit Sales (K Units) of Key Manufacturers (2021–2026)

Table 6. Global Blood & Tissue DNA Kit Sales Market Share by Manufacturers (2021–2026)

Table 7. Global Blood & Tissue DNA Kit Revenue (US$ Million) by Manufacturers (2021–2026)

Table 8. Global Blood & Tissue DNA Kit Revenue Share by Manufacturers (2021–2026)

Table 9. Global Market Blood & Tissue DNA Kit Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 10. Global Key Players of Blood & Tissue DNA Kit, Industry Ranking, 2023 vs 2024 vs 2025

Table 11. Global Key Manufacturers of Blood & Tissue DNA Kit, Manufacturing Sites and Headquarters

Table 12. Global Key Manufacturers of Blood & Tissue DNA Kit, Product Types and Applications

Table 13. Global Key Manufacturers of Blood & Tissue DNA Kit, Date of Entry into the Industry

Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Global Blood & Tissue DNA Kit Companies by Tier (Tier 1, Tier 2, Tier 3), based on Blood & Tissue DNA Kit Revenue, 2025

Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 17. Global Blood & Tissue DNA Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 18. Global Blood & Tissue DNA Kit Sales by Region (K Units), 2021–2026

Table 19. Global Blood & Tissue DNA Kit Sales Market Share by Region (2021–2026)

Table 20. Global Blood & Tissue DNA Kit Sales by Region (K Units), 2027–2032

Table 21. Global Blood & Tissue DNA Kit Sales Market Share by Region (2027–2032)

Table 22. Global Blood & Tissue DNA Kit Revenue by Region (US$ Million), 2021–2026

Table 23. Global Blood & Tissue DNA Kit Revenue Market Share by Region (2021–2026)

Table 24. Global Blood & Tissue DNA Kit Revenue by Region (US$ Million), 2027–2032

Table 25. Global Blood & Tissue DNA Kit Revenue Market Share by Region (2027–2032)

Table 26. North America Blood & Tissue DNA Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 27. North America Blood & Tissue DNA Kit Sales by Country (K Units), 2021–2026

Table 28. North America Blood & Tissue DNA Kit Sales by Country (K Units), 2027–2032

Table 29. North America Blood & Tissue DNA Kit Revenue by Country (US$ Million), 2021–2026

Table 30. North America Blood & Tissue DNA Kit Revenue by Country (US$ Million), 2027–2032

Table 31. Europe Blood & Tissue DNA Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 32. Europe Blood & Tissue DNA Kit Sales by Country (K Units), 2021–2026

Table 33. Europe Blood & Tissue DNA Kit Sales by Country (K Units), 2027–2032

Table 34. Europe Blood & Tissue DNA Kit Revenue by Country (US$ Million), 2021–2026

Table 35. Europe Blood & Tissue DNA Kit Revenue by Country (US$ Million), 2027–2032

Table 36. Asia Pacific Blood & Tissue DNA Kit Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 37. Asia Pacific Blood & Tissue DNA Kit Sales by Region (K Units), 2021–2026

Table 38. Asia Pacific Blood & Tissue DNA Kit Sales by Region (K Units), 2027–2032

Table 39. Asia Pacific Blood & Tissue DNA Kit Revenue by Region (US$ Million), 2021–2026

Table 40. Asia Pacific Blood & Tissue DNA Kit Revenue by Region (US$ Million), 2027–2032

Table 41. Latin America Blood & Tissue DNA Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 42. Latin America Blood & Tissue DNA Kit Sales by Country (K Units), 2021–2026

Table 43. Latin America Blood & Tissue DNA Kit Sales by Country (K Units), 2027–2032

Table 44. Latin America Blood & Tissue DNA Kit Revenue by Country (US$ Million), 2021–2026

Table 45. Latin America Blood & Tissue DNA Kit Revenue by Country (US$ Million), 2027–2032

Table 46. Middle East and Africa Blood & Tissue DNA Kit Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 47. Middle East and Africa Blood & Tissue DNA Kit Sales by Country (K Units), 2021–2026

Table 48. Middle East and Africa Blood & Tissue DNA Kit Sales by Country (K Units), 2027–2032

Table 49. Middle East and Africa Blood & Tissue DNA Kit Revenue by Country (US$ Million), 2021–2026

Table 50. Middle East and Africa Blood & Tissue DNA Kit Revenue by Country (US$ Million), 2027–2032

Table 51. Global Blood & Tissue DNA Kit Sales (K Units) by Type (2021–2026)

Table 52. Global Blood & Tissue DNA Kit Sales (K Units) by Type (2027–2032)

Table 53. Global Blood & Tissue DNA Kit Sales Market Share by Type (2021–2026)

Table 54. Global Blood & Tissue DNA Kit Sales Market Share by Type (2027–2032)

Table 55. Global Blood & Tissue DNA Kit Revenue (US$ Million) by Type (2021–2026)

Table 56. Global Blood & Tissue DNA Kit Revenue (US$ Million) by Type (2027–2032)

Table 57. Global Blood & Tissue DNA Kit Revenue Market Share by Type (2021–2026)

Table 58. Global Blood & Tissue DNA Kit Revenue Market Share by Type (2027–2032)

Table 59. Global Blood & Tissue DNA Kit Price (US$/Unit) by Type (2021–2026)

Table 60. Global Blood & Tissue DNA Kit Price (US$/Unit) by Type (2027–2032)

Table 61. Global Blood & Tissue DNA Kit Sales (K Units) by Application (2021–2026)

Table 62. Global Blood & Tissue DNA Kit Sales (K Units) by Application (2027–2032)

Table 63. Global Blood & Tissue DNA Kit Sales Market Share by Application (2021–2026)

Table 64. Global Blood & Tissue DNA Kit Sales Market Share by Application (2027–2032)

Table 65. Global Blood & Tissue DNA Kit Revenue (US$ Million) by Application (2021–2026)

Table 66. Global Blood & Tissue DNA Kit Revenue (US$ Million) by Application (2027–2032)

Table 67. Global Blood & Tissue DNA Kit Revenue Market Share by Application (2021–2026)

Table 68. Global Blood & Tissue DNA Kit Revenue Market Share by Application (2027–2032)

Table 69. Global Blood & Tissue DNA Kit Price (US$/Unit) by Application (2021–2026)

Table 70. Global Blood & Tissue DNA Kit Price (US$/Unit) by Application (2027–2032)

Table 71. QIAGEN Company Information

Table 72. QIAGEN Description and Business Overview

Table 73. QIAGEN Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 74. QIAGEN Blood & Tissue DNA Kit Product

Table 75. QIAGEN Recent Developments/Updates

Table 76. Thermo Fisher Scientific Company Information

Table 77. Thermo Fisher Scientific Description and Business Overview

Table 78. Thermo Fisher Scientific Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 79. Thermo Fisher Scientific Blood & Tissue DNA Kit Product

Table 80. Thermo Fisher Scientific Recent Developments/Updates

Table 81. Sigma-Aldrich (Merck) Company Information

Table 82. Sigma-Aldrich (Merck) Description and Business Overview

Table 83. Sigma-Aldrich (Merck) Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 84. Sigma-Aldrich (Merck) Blood & Tissue DNA Kit Product

Table 85. Sigma-Aldrich (Merck) Recent Developments/Updates

Table 86. Roche Company Information

Table 87. Roche Description and Business Overview

Table 88. Roche Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 89. Roche Blood & Tissue DNA Kit Product

Table 90. Roche Recent Developments/Updates

Table 91. Axygen (Corning) Company Information

Table 92. Axygen (Corning) Description and Business Overview

Table 93. Axygen (Corning) Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 94. Axygen (Corning) Blood & Tissue DNA Kit Product

Table 95. Axygen (Corning) Recent Developments/Updates

Table 96. Analytik Jena Company Information

Table 97. Analytik Jena Description and Business Overview

Table 98. Analytik Jena Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 99. Analytik Jena Blood & Tissue DNA Kit Product

Table 100. Analytik Jena Recent Developments/Updates

Table 101. Promega Company Information

Table 102. Promega Description and Business Overview

Table 103. Promega Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 104. Promega Blood & Tissue DNA Kit Product

Table 105. Promega Recent Developments/Updates

Table 106. Zymo Research Company Information

Table 107. Zymo Research Description and Business Overview

Table 108. Zymo Research Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 109. Zymo Research Blood & Tissue DNA Kit Product

Table 110. Zymo Research Recent Developments/Updates

Table 111. Illumina Company Information

Table 112. Illumina Description and Business Overview

Table 113. Illumina Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 114. Illumina Blood & Tissue DNA Kit Product

Table 115. Illumina Recent Developments/Updates

Table 116. Macherey-Nagel Company Information

Table 117. Macherey-Nagel Description and Business Overview

Table 118. Macherey-Nagel Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 119. Macherey-Nagel Blood & Tissue DNA Kit Product

Table 120. Macherey-Nagel Recent Developments/Updates

Table 121. Bio-Rad Company Information

Table 122. Bio-Rad Description and Business Overview

Table 123. Bio-Rad Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 124. Bio-Rad Blood & Tissue DNA Kit Product

Table 125. Bio-Rad Recent Developments/Updates

Table 126. Omega Bio-tek Company Information

Table 127. Omega Bio-tek Description and Business Overview

Table 128. Omega Bio-tek Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 129. Omega Bio-tek Blood & Tissue DNA Kit Product

Table 130. Omega Bio-tek Recent Developments/Updates

Table 131. Geneaid Company Information

Table 132. Geneaid Description and Business Overview

Table 133. Geneaid Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 134. Geneaid Blood & Tissue DNA Kit Product

Table 135. Geneaid Recent Developments/Updates

Table 136. Lucigen (Biosearch Technologies) Company Information

Table 137. Lucigen (Biosearch Technologies) Description and Business Overview

Table 138. Lucigen (Biosearch Technologies) Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 139. Lucigen (Biosearch Technologies) Blood & Tissue DNA Kit Product

Table 140. Lucigen (Biosearch Technologies) Recent Developments/Updates

Table 141. Norgen Company Information

Table 142. Norgen Description and Business Overview

Table 143. Norgen Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 144. Norgen Blood & Tissue DNA Kit Product

Table 145. Norgen Recent Developments/Updates

Table 146. MGI Tech Co., Ltd. Company Information

Table 147. MGI Tech Co., Ltd. Description and Business Overview

Table 148. MGI Tech Co., Ltd. Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 149. MGI Tech Co., Ltd. Blood & Tissue DNA Kit Product

Table 150. MGI Tech Co., Ltd. Recent Developments/Updates

Table 151. BioVision Company Information

Table 152. BioVision Description and Business Overview

Table 153. BioVision Blood & Tissue DNA Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 154. BioVision Blood & Tissue DNA Kit Product

Table 155. BioVision Recent Developments/Updates

Table 156. Key Raw Materials Lists

Table 157. Raw Materials Key Suppliers Lists

Table 158. Blood & Tissue DNA Kit Distributors List

Table 159. Blood & Tissue DNA Kit Customers List

Table 160. Blood & Tissue DNA Kit Market Trends

Table 161. Blood & Tissue DNA Kit Market Drivers

Table 162. Blood & Tissue DNA Kit Market Challenges

Table 163. Blood & Tissue DNA Kit Market Restraints

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

Table 167. Authors List of This Report

List of Figures

Figure 1. Product Picture of Blood & Tissue DNA Kit

Figure 2. Global Blood & Tissue DNA Kit Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Blood & Tissue DNA Kit Market Share by Type: 2025 & 2032

Figure 4. Whole Blood Product Picture

Figure 5. Plasma or Serum Product Picture

Figure 6. Buffy Coat Product Picture

Figure 7. Global Blood & Tissue DNA Kit Market Value by Technology (US$ Million), 2021–2032

Figure 8. Global Blood & Tissue DNA Kit Market Share by Technology: 2025 vs 2032

Figure 9. Spin Column-based DNA Kit Product Picture

Figure 10. Magnetic Bead-based DNA Kit Product Picture

Figure 11. Precipitation-based DNA Kit Product Picture

Figure 12. Global Blood & Tissue DNA Kit Market Value by Application (US$ Million), 2021–2032

Figure 13. Global Blood & Tissue DNA Kit Market Share by Application: 2025 & 2032

Figure 14. R&D Organisations

Figure 15. Biotechnology Companies

Figure 16. Global Blood & Tissue DNA Kit Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Blood & Tissue DNA Kit Market Size (US$ Million), 2021–2032

Figure 18. Global Blood & Tissue DNA Kit Sales (K Units), 2021–2032

Figure 19. Global Blood & Tissue DNA Kit Average Price (US$/Unit), 2021–2032

Figure 20. Blood & Tissue DNA Kit Report Years Considered

Figure 21. Blood & Tissue DNA Kit Sales Share by Manufacturers in 2025

Figure 22. Global Blood & Tissue DNA Kit Revenue Share by Manufacturers in 2025

Figure 23. Top 5 and Top 10 Global Blood & Tissue DNA Kit Players: Market Share by Revenue in Blood & Tissue DNA Kit in 2025

Figure 24. Blood & Tissue DNA Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 25. Global Blood & Tissue DNA Kit Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 26. North America Blood & Tissue DNA Kit Sales Market Share by Country (2021–2032)

Figure 27. North America Blood & Tissue DNA Kit Revenue Market Share by Country (2021–2032)

Figure 28. United States Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. Canada Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Europe Blood & Tissue DNA Kit Sales Market Share by Country (2021–2032)

Figure 31. Europe Blood & Tissue DNA Kit Revenue Market Share by Country (2021–2032)

Figure 32. Germany Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. France Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. U.K. Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Italy Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Russia Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Asia Pacific Blood & Tissue DNA Kit Sales Market Share by Region (2021–2032)

Figure 38. Asia Pacific Blood & Tissue DNA Kit Revenue Market Share by Region (2021–2032)

Figure 39. China Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Japan Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. South Korea Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. India Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Australia Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. China Taiwan Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Southeast Asia Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Latin America Blood & Tissue DNA Kit Sales Market Share by Country (2021–2032)

Figure 47. Latin America Blood & Tissue DNA Kit Revenue Market Share by Country (2021–2032)

Figure 48. Mexico Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Brazil Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Argentina Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Colombia Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Middle East and Africa Blood & Tissue DNA Kit Sales Market Share by Country (2021–2032)

Figure 53. Middle East and Africa Blood & Tissue DNA Kit Revenue Market Share by Country (2021–2032)

Figure 54. Turkey Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Saudi Arabia Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. UAE Blood & Tissue DNA Kit Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Global Sales Market Share of Blood & Tissue DNA Kit by Type (2021–2032)

Figure 58. Global Revenue Market Share of Blood & Tissue DNA Kit by Type (2021–2032)

Figure 59. Global Blood & Tissue DNA Kit Price (US$/Unit) by Type (2021–2032)

Figure 60. Global Sales Market Share of Blood & Tissue DNA Kit by Application (2021–2032)

Figure 61. Global Revenue Market Share of Blood & Tissue DNA Kit by Application (2021–2032)

Figure 62. Global Blood & Tissue DNA Kit Price (US$/Unit) by Application (2021–2032)

Figure 63. Blood & Tissue DNA Kit Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions